Bianchi F, Ginggen A, Tardy Y
Codman Neuro Sciences SA RL, Le Locle, Switzerland.
Anaesthesia. 2008 Sep;63(9):972-8. doi: 10.1111/j.1365-2044.2008.05516.x.
This study evaluated the stability and the compatibility of mixtures of morphine sulphate, bupivacaine, and clonidine hydrochloride and of hydromorphone, bupivacaine, and clonidine hydrochloride, when used in constant flow implantable pumps under simulated clinical use conditions. The pumps were filled with drug mixtures and incubated at 37 degrees C for a period of 90 days. Aliquots were sampled monthly from the reservoir and catheter outlet and the drug concentrations analysed using validated chromatography methods. Individual materials from the infusion system were immersed in the drug mixtures and stored at 37 degrees C for 60 weeks and evaluated for mechanical performance for compatibility testing. Both drug mixtures were found to be stable over 90 days in the pump at 37 degrees C. All device materials retained acceptable mechanical performance following exposure. These results demonstrate that both drug mixtures are stable when maintained at simulated body temperature in an implantable infusion system for 90 days.
本研究评估了硫酸吗啡、布比卡因和盐酸可乐定的混合物以及氢吗啡酮、布比卡因和盐酸可乐定的混合物在模拟临床使用条件下用于恒流植入式泵时的稳定性和相容性。将泵填充药物混合物,并在37℃下孵育90天。每月从储液器和导管出口采集等分试样,并使用经过验证的色谱方法分析药物浓度。将输液系统的各个材料浸入药物混合物中,在37℃下储存60周,并评估其机械性能以进行相容性测试。发现两种药物混合物在37℃的泵中90天内均稳定。暴露后,所有装置材料均保持可接受的机械性能。这些结果表明,两种药物混合物在植入式输液系统中维持在模拟体温下90天时均稳定。